Type 2 diabetes in children: a growing epidemic

Erin L St Onge1, Carol A Motycka, Renee L Rose

  • 1University of Florida College of Pharmacy, Gainesville, Florida.

Insights

Type 2 diabetes in children is rising, linked to obesity and inactivity. Lifestyle changes are key, but medication may be needed, with healthcare providers guiding treatment decisions.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Public Health

Background:

  • Type 2 diabetes is a growing concern in children, often linked to obesity and sedentary lifestyles.
  • Untreated diabetes and obesity can lead to serious health complications like cardiovascular disease, nephropathy, and retinopathy.
  • The healthcare system faces significant strain due to the rising prevalence of pediatric obesity and diabetes.

Purpose of the Study:

  • To review the correlation between pediatric type 2 diabetes, obesity, and lifestyle factors.
  • To discuss the role of lifestyle modifications and pharmacological interventions in managing pediatric diabetes.
  • To highlight the importance of healthcare practitioner education for informed patient decision-making.

Main Methods:

  • Literature review on pediatric type 2 diabetes, obesity, and treatment options.
  • Analysis of existing studies on the safety and efficacy of weight management and diabetes medications in children.
  • Synthesis of information regarding the impact of lifestyle and pharmacological therapies.

Main Results:

  • Lifestyle changes (exercise, healthy eating) are recommended but not always sufficient for blood sugar control.
  • Orlistat and sibutramine show promise for obesity treatment in pediatric populations.
  • Metformin and insulin are approved diabetes medications for children and adolescents.

Conclusions:

  • Healthcare providers must educate families on obesity-related diseases and treatment options.
  • Informed decisions about medication benefits and risks are crucial for managing pediatric diabetes.
  • Integrated approaches involving lifestyle changes and appropriate pharmacological treatments are essential.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...